For many years, investment trusts have quietly served as a valuable asset for individual savers.

These financial vehicles have allowed everyday investors to access groundbreaking and potentially profitable innovations throughout history, from the 19th-century railroads to today’s advances in artificial intelligence, even with modest investments.

Renowned for their focus on long-term growth, these trusts align perfectly with the goals of those planning for retirement.

While their advantages might be underrecognized domestically, they haven’t gone unnoticed by Boaz Weinstein of the U.S.-based Saba Capital. Weinstein has been persistently challenging trust boards in his attempt to seize control of these trusts at discounted rates, despite significant opposition from other shareholders.

Though his efforts have been met with resistance, Weinstein remains undeterred, leaving trusts like Edinburgh Worldwide embroiled in an ongoing battle.

He has been rebuffed but will not give up, and his refusal to accept defeat has plunged trusts such as Edinburgh Worldwide into a state of long-running siege.

Ruthless: US predator Boaz Weinstein has been waging a war of attrition against trust boards via his vehicle Saba Capital

At Edinburgh, he has called a vote to remove the directors and replace them with his own candidates, less than two weeks after a previous effort hit the rocks.

Weinstein is relying on investor fatigue to get his way. His approach is to wear down opposing shareholders until they finally capitulate. This is not acceptable.

As I recently wrote in these pages, City regulators and the Government must not sit idly by while private investors’ interests are trampled so cynically.

The Association of Investment Companies has written to the City watchdog, the Financial Conduct Authority, and to the Department for Business and Trade calling for action to protect retail shareholders.

Saba has woken up a sometimes complacent sector. Private investors have mobilised to defend their trusts. 

But it is unfair that trusts have to keep on achieving record turnouts to prevent Saba taking control against the desires of the vast majority of independent shareholders.

Carpet-baggers such as Weinstein should not be permitted to force repeated votes on basically the same proposals. Regulators need to impose a limit. 

One strike and you’re out for a year, two strikes and you’re out for good, seems reasonable to me. To combat apathy, there should be rule changes to permit small investors who hold shares through platforms to vote by default with the board. 

Related-party transaction rules could also be used to block Saba from installing its own Trojan Horse directors onto trust boards with carte blanche to change the managers and the strategy of the trust to their own advantage.

Saba is making a mockery of shareholder democracy and treating savers with contempt. Enough is enough.

They’re back!

Simon Peckham and his crew, who were among the City’s most prolific dealmakers with their former company Melrose, are back on the takeover trail with their newish venture, Rosebank. 

Peckham has his sights on two businesses owned by private equity firm American Securities.

At Melrose, Peckham and his cohorts generated a total shareholder return of nearly 3400 per cent for their backers from their float in 2003 until the group was broken up a couple of years ago.

The strategy deployed was a private equity-style formula of ‘buy, improve, sell,’ undertaken on the public markets. 

Peckham now believes he can do it all over again, and on the much-maligned London stock market to boot.

His decision to float Rosebank in London rather than to go the private equity route or list in New York is in itself a vote of confidence in the UK. 

It is also refreshing to see a British company embark on US takeovers, when so much of the tide is in the opposite direction.

So can he recreate his glory days?

These acquisitions are from a private equity owner, as was Rosebank’s first purchase last year when it bought Electrical Components International from Cerberus Capital Management for more than £1.5billion. 

This raises the question of how much more value Rosebank can extract from assets that have already been given the private-equity treatment.

Peckham does, however, have a track record at Melrose of doing precisely that.

The takeover of grand old British engineer GKN in 2018 was controversial and Dowlais, the automotive arm spun off out of Melrose, is now owned by US firm American Axle.

But it would be foolish to dismiss any team with a record like Rosebank’s. And when Peckham says his aim is to make a lot of profit in the UK and pay a lot of tax here to fund the NHS, one can only applaud.

DIY INVESTING PLATFORMS

AJ Bell

AJ Bell

Easy investing and ready-made portfolios

Hargreaves Lansdown

Hargreaves Lansdown

Free fund dealing and investment ideas

interactive investor

interactive investor

Flat-fee investing from £4.99 per month

Freetrade

Freetrade

Investing Isa now free on basic plan

Trading 212

Trading 212

Free share dealing and no account fee

Affiliate links: If you take out a product This is Money may earn a commission. These deals are chosen by our editorial team, as we think they are worth highlighting. This does not affect our editorial independence.

Compare the best investing account for you